Lymphatic PD-L1 Expression Restricts Tumor-Specific CD8+ T-cell Responses
Open Access
- 7 June 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (15) , 4133-4144
Abstract
Lymph node (LN)–resident lymphatic endothelial cells (LEC) mediate peripheral tolerance by self-antigen presentation on MHC-I and constitutive expression of T-cell inhibitory molecules, including PD-L1 (CD274). Tumor-associated LECs also upregulate PD-L1, but the specific role of lymphatic PD-L1 in tumor immunity is not well understood. In this study, we generated a mouse model lacking lymphatic PD-L1 expression and challenged these mice with two orthotopic tumor models, B16F10 melanoma and MC38 colorectal carcinoma. Lymphatic PD-L1 deficiency resulted in consistent expansion of tumor-specific CD8+ T cells in tumor-draining LNs in both tumor models, reduced primary tumor growth in the MC38 model, and increased efficacy of adoptive T-cell therapy in the B16F10 model. Strikingly, lymphatic PD-L1 acted primarily by inducing apoptosis in tumor-specific CD8+ central memory T cells. Overall, these findings demonstrate that LECs restrain tumor-specific immunity via PD-L1, which may explain why some patients with cancer without PD-L1 expression in the tumor microenvironment still respond to PD-L1/PD-1–targeted immunotherapy.Significance: A new lymphatic-specific PD-L1 knockout mouse model reveals that lymphatic endothelial PD-L1 expression reduces tumor immunity, inducing apoptosis in tumor-specific CD8+ central memory cells in tumor-draining lymph nodes.Keywords
All Related Versions
Funding Information
- Swiss National Science Foundation (310030_166490, 310030B_185392)
- Vontobel Foundation and Krebsliga Zurich
This publication has 50 references indexed in Scilit:
- αB-crystallin/HspB5 regulates endothelial–leukocyte interactions by enhancing NF-κB-induced up-regulation of adhesion molecules ICAM-1, VCAM-1 and E-selectinAngiogenesis, 2013
- A simple and rapid nonviral approach to efficiently transfect primary tissue–derived cells using polyethylenimineNature Protocols, 2012
- Afferent lymph–derived T cells and DCs use different chemokine receptor CCR7–dependent routes for entry into the lymph node and intranodal migrationNature Immunology, 2011
- Genes regulating lymphangiogenesis control venous valve formation and maintenance in miceJournal of Clinical Investigation, 2011
- Bcl-2 Allows Effector and Memory CD8+ T Cells To Tolerate Higher Expression of BimThe Journal of Immunology, 2011
- Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditionsJournal of Experimental Medicine, 2010
- Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentationJournal of Experimental Medicine, 2010
- PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2007
- CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct MechanismsMolecular and Cellular Biology, 2005
- MHC class II presentation of endogenously expressed antigens by transfected dendritic cellsGene Therapy, 2001